Skip to content

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

Multi-component Interventions for Patients and Providers to Increase HPV Vaccination in a Network of Pediatric Clinics in Houston, TX

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03111251
Enrollment
1000
Registered
2017-04-12
Start date
2015-03-01
Completion date
2019-02-28
Last updated
2020-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus (HPV)

Brief summary

The purpose of the study is to determine the comparative effectiveness of a provider-only intervention and a parent plus provider intervention to increase initiation of HPV vaccination among male and female patients ages 11-17 in a large pediatric clinic network in the greater Houston area. The hypothesis is that HPV vaccine initiation will be higher in clinics randomized to the parent plus provider intervention compared with clinics randomized to the provider-only intervention.

Interventions

BEHAVIORALProvider assessment and feedback

Tailored immunization reports highlighting adolescent vaccination rates at the individual, clinic and network levels are distributed by clinic champions every quarter. Reports track vaccination rates over time and allow physicians to compare their rates to the national goal.

An EHR-based reminder system informs providers when patients are due or overdue for HPV vaccination.

Provider education is being delivered through a comprehensive online continuing education activity that is tailored specifically to physicians, nurses, and clinical staff at TCP practices. It focuses on HPV vaccination best practices and communicating with parents about the HPV vaccine.

Patient reminders are delivered through MyChart, the clinics' online personal health record system, to inform patients (parents) that they are due or overdue for HPV vaccination.

The parent education intervention (currently in development) will employ innovative strategies to identify and overcome barriers to HPV vaccination.

Sponsors

Cancer Prevention Research Institute of Texas
CollaboratorOTHER
Baylor College of Medicine
CollaboratorOTHER
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient at a Texas Children's Pediatrics clinic * Patient had not initiated the HPV vaccination series at baseline

Exclusion criteria

\- Patient had completed the HPV vaccination series at baseline

Design outcomes

Primary

MeasureTime frame
Change in percent of HPV vaccination initiationbaseline, 3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026